Servier Bio-innovation Llc

This study tested a new drug called S227928, alone or with another drug (venetoclax), in people with certain blood cancers (AML, MDS/AML, or CMML) that returned or didn't respond to prior treatment. The goal was to find a safe dose and see if it could help control the cancer. The…

This early-stage trial tested a combination of ivosidenib (a targeted pill) plus two immunotherapy drugs (nivolumab and ipilimumab) in 7 adults with advanced IDH1-mutated bile duct cancer that had already been treated. The study was stopped by the sponsor before the expansion pha…